Expert Teaches on Testosterone and Hypogonadism. This webcast will discuss Testosterone and Hypogonadism. This program will discuss the presentation and diagnosis of male hypogonadism including the various limitations and nuances of testing. The program will also discuss the treatment of hypogonadism with testosterone including an overview of the different formulations. Finally, the program will go into depth with monitoring of treatment including a discussion of potential side effects and contraindications.
Now we’re in the age of social media, Testosterone therapy has once again gained substantial interest and attention. You’ve probably heard the commercials for “low T” treatment and so have your patients. Between 2001 and 2011, testosterone use in the US has tripled. FOR-profit “low T” clinics have popped up all around the country to serve the increasing appetite for testosterone replacement.
With more and more patients asking about low-T, we wanted to bring you the most up-to-date and evidenced-based recommendations for the testing, treatment, and monitoring of hypogonadism. For today’s presentation, we’ve invited an expert from Ohio State University. Dr Roger Harty is an Assistant Professor of Endocrinology, Diabetes and Metabolism.
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to:
- Review the recommended workup and limitations of testing for male hypogonadism
- Review the therapeutic options and monitoring recommendations for treatment of male hypogonadism
You’ll also learn about the following:
- Testosterone Levels with Age
- Contraindications
- Testosterone Formulations
- Monitoring Treatment
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.